621 results on '"Khammari, Amir"'
Search Results
2. Panniculitis does not predict clinical response in patients with advanced melanoma under targeted therapy
3. Analysis of cost-effectiveness of chemotherapeutic agents and new therapies for the management of unresectable and metastatic melanoma
4. Machine learning algorithm to predict response to immunotherapy in real-life settings for patients with advanced melanoma
5. Epidemiology and characteristics of acral lentiginous melanoma compared to lentigo melanoma in France: a multicentric retrospective study from the French cohort RIC-Mel database
6. Predictive factors of response to vismodegib: a French study of 61 patients with multiple or locally advanced basal cell carcinoma
7. Update on Cutibacterium acnes
8. Pro‐inflammatory activity of Cutibacterium acnes phylotype IA1 and extracellular vesicles: An in vitro study.
9. Phase I/II clinical trial of adoptive cell transfer of sorted specific T cells for metastatic melanoma patients
10. Skin Barrier and Microbiome
11. Efficacy of Spironolactone Compared with Doxycycline in Moderate Acne in Adult Females: Results of the Multicentre, Controlled, Randomized, Double-blind Prospective and Parallel Female Acne Spironolactone vs doxyCycline Efficacy (FASCE) Study
12. Complete spontaneous regression of primary Merkel cell carcinoma with tumoural infiltration: a systematic review
13. Cardiac adverse events associated with anti-PD-1 therapy in patients treated for advanced melanoma: relevance of dosing troponin T levels
14. A dermocosmetic regimen is able to mitigate skin sensitivity induced by a retinoid‐based fixed combination treatment for acne: Results of a randomized clinical trial.
15. Acne microbiome: From phyla to phylotypes.
16. The amorphization of metal nanoparticles in graphitic shells under laser pulses
17. Neurological toxicities of targeted therapies in melanoma: a multicenter national observational study of the French Group of Skin Cancers (Groupe de Cancérologie Cutanée, GCC)
18. 749 Early phase oncology experience on the use of an oncolytic adenovirus encoding for TNFa and IL-2 for the treatment of solid tumors – Interim results
19. Update on Cutibacterium acnes
20. The Skin Microbiome: A New Actor in Inflammatory Acne
21. Tumor infiltrating lymphocytes as adjuvant treatment in stage III melanoma patients with only one invaded lymph node after complete resection: results from a multicentre, randomized clinical phase III trial
22. Foetal skin cells in wound healing: a promising tool for clinical application
23. Assessment of seven protocols to prepare Cutibacterium acnes bacterial lysates to measure its immunogenic potential and review of the literature
24. Acne microbiome: From phyla to phylotypes
25. Efficacy and safety of nivolumab in metastatic melanoma: real-world practice
26. Efficacy of imiquimod in the management of lentigo maligna
27. Peripheral CD8 effector-memory type 1 T-cells correlate with outcome in ipilimumab-treated stage IV melanoma patients
28. FASCE, the benefit of spironolactone for treating acne in women: study protocol for a randomized double-blind trial
29. Transcriptomic features of tumour-infiltrating CD4lowCD8high double positive αβ T cells in melanoma
30. CICAFAST: comparison of a biological dressing composed of fetal fibroblasts and keratinocytes on a split-thickness skin graft donor site versus a traditional dressing: a randomized controlled trial
31. Chemotherapy efficacy after first-line immunotherapy in 18 advanced melanoma patients
32. Data from Emergence of High-Avidity Melan-A–Specific Clonotypes as a Reflection of Anti–PD-1 Clinical Efficacy
33. Supplemental figure legends from Emergence of High-Avidity Melan-A–Specific Clonotypes as a Reflection of Anti–PD-1 Clinical Efficacy
34. Figure S4 from Emergence of High-Avidity Melan-A–Specific Clonotypes as a Reflection of Anti–PD-1 Clinical Efficacy
35. Supplementary Figure 5 from Increases in Absolute Lymphocytes and Circulating CD4+ and CD8+ T Cells Are Associated with Positive Clinical Outcome of Melanoma Patients Treated with Ipilimumab
36. Supplementary Figure from Frequency and Genomic Aspects of Intrinsic Resistance to Vismodegib in Locally Advanced Basal Cell Carcinoma
37. Supplementary Table 1 from Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab
38. Supplementary Table 3 from Increases in Absolute Lymphocytes and Circulating CD4+ and CD8+ T Cells Are Associated with Positive Clinical Outcome of Melanoma Patients Treated with Ipilimumab
39. Supplementary Figure 4 from Increases in Absolute Lymphocytes and Circulating CD4+ and CD8+ T Cells Are Associated with Positive Clinical Outcome of Melanoma Patients Treated with Ipilimumab
40. Supplementary Data from Frequency and Genomic Aspects of Intrinsic Resistance to Vismodegib in Locally Advanced Basal Cell Carcinoma
41. Supplementary Figure 3 from Increases in Absolute Lymphocytes and Circulating CD4+ and CD8+ T Cells Are Associated with Positive Clinical Outcome of Melanoma Patients Treated with Ipilimumab
42. Supplementary Table 1 from Increases in Absolute Lymphocytes and Circulating CD4+ and CD8+ T Cells Are Associated with Positive Clinical Outcome of Melanoma Patients Treated with Ipilimumab
43. Supplementary Table 2 from Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab
44. Supplementary Figure 1 from Increases in Absolute Lymphocytes and Circulating CD4+ and CD8+ T Cells Are Associated with Positive Clinical Outcome of Melanoma Patients Treated with Ipilimumab
45. Supplementary Table 2 from Increases in Absolute Lymphocytes and Circulating CD4+ and CD8+ T Cells Are Associated with Positive Clinical Outcome of Melanoma Patients Treated with Ipilimumab
46. Supplementary Table 3 from Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab
47. Supplementary Figure 2 from Increases in Absolute Lymphocytes and Circulating CD4+ and CD8+ T Cells Are Associated with Positive Clinical Outcome of Melanoma Patients Treated with Ipilimumab
48. Supplementary Figure 3 from Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab
49. The mechanosensitive TRPV2 calcium channel promotes human melanoma invasiveness and metastatic potential
50. 5-fluorouracil chemowraps for the treatment of multiple actinic keratoses
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.